Cargando…

Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritis

PURPOSE: To estimate the cost-effectiveness and budget impact of viscosupplementation with one intra-articular (IA) injection of 6 mL hylan G-F 20 (Synvisc-One(®)) and with three injections of 2 mL hylan G-F 20 (Synvisc(®)3×2) in knee osteoarthritis (OA) patients compared with conventional support t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Migliore, Alberto, Integlia, Davide, Pompilio, Giuseppe, Di Giuseppe, Francesca, Aru, Cinzia, Brown, Tray
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659788/ https://www.ncbi.nlm.nih.gov/pubmed/31413608 http://dx.doi.org/10.2147/CEOR.S194669

Ejemplares similares

Viscosupplementation for knee osteoarthritis: a focus on Hylan G-F 20
por: Webb, David, et al.
Publicado: (2018)

Bilateral Hip Joint Hylan G-F 20 Granulomatous Synovitis due to Viscosupplementation Injections
por: Weinrauch, Patrick, et al.
Publicado: (2014)

Hylan GF-20 Viscosupplementation in the Treatment of Symptomatic Osteoarthritis of the Knee: Clinical Effect Survivorship at 5 Years
por: Boutefnouchet, Tarek, et al.
Publicado: (2017)

IMPROVEMENTS IN HIP OSTEOARTHRITIS WITH LAVAGE, TRIAMCINOLONE AND HYLAN G-F20
por: REZENDE, MÁRCIA UCHÔA DE, et al.
Publicado: (2020)

Viscosupplementation in the treatment of osteoarthritis
por: Migliore, Alberto, et al.
Publicado: (2012)

Hylan G-F 20: Review of its Safety and Efficacy in the Management of Joint Pain in Osteoarthritis
por: Migliore, A., et al.
Publicado: (2010)

When is indicated viscosupplementation in hip osteoarthritis?
por: Francesco, Pogliacomi, et al.
Publicado: (2019)

Total Knee Replacement Delayed With Hylan G-F 20 Use in Patients With Grade IV Osteoarthritis
por: Waddell, David D., et al.
Publicado: (2007)

Managing joint pain in osteoarthritis: safety and efficacy of hylan G-F 20
por: Conduah, Augustine H, et al.
Publicado: (2009)

Viscosupplementation: Managed Care Issues for Osteoarthritis of the Knee
por: Arnold, William, et al.
Publicado: (2007)

Open-label Study of Initial and Repeat Treatment Cycles of Hylan G-F 20 in Patients with Symptomatic Knee Osteoarthritis
por: Heger, Robert, et al.
Publicado: (2016)

Budget Impact di afatinib per il trattamento in prima linea del Non Small Cell Lung Cancer (NSCLC) con mutazioni non comuni EGFR
por: Pompilio, Giuseppe, et al.
Publicado: (2022)

HYLAN G-F 20 VERSUS TRIAMCINOLONE IN THE TREATMENT OF PRIMARY SHOULDER OSTEOARTHRITIS. RANDOMIZED TRIAL
por: TORTATO, SIMONE, et al.
Publicado: (2022)

Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis
Publicado: (2022)

Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis
por: Pereira, Tiago V, et al.
Publicado: (2022)

EUROVISCO Good Practice Recommendations for a First Viscosupplementation in Patients with Knee Osteoarthritis
por: Conrozier, Thierry, et al.
Publicado: (2022)

Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group
por: Conrozier, Thierry, et al.
Publicado: (2021)

Costo per responder del metotrexato rispetto ad altre terapie in pazienti con psoriasi a placche da moderata a grave in Italia
por: Pompilio, Giuseppe, et al.
Publicado: (2022)

Weekly injections of Hylan G-F 20 delay cartilage degeneration in partial meniscectomized rat knees
por: Yanagisawa, Katsuaki, et al.
Publicado: (2016)

Evaluation of Hylan G-F 20 Treatment with Opioid Prescriptions and Intraarticular Corticosteroid Injections in Patients with Osteoarthritis of the Knee Using a Claims Database
por: Langworthy, Michael J., et al.
Publicado: (2020)

Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis
por: Migliore, Alberto, et al.
Publicado: (2021)

Worsen depression after viscosupplementation treatment for geriatric people with knee osteoarthritis?
por: Chen, Yu-Pin, et al.
Publicado: (2019)

Viscosupplementation for Osteoarthritis of the Knee: A Key Opinion Leader Panel Discussion
por: Bert, Jack, et al.
Publicado: (2018)

Multicentre, prospective, open study to evaluate the safety and efficacy of hylan G-F 20 in knee osteoarthritis subjects presenting with pain following arthroscopic meniscectomy
por: Huskin, J. P., et al.
Publicado: (2008)

Retrospective Comparative Analysis of Opioid Use and Intra-Articular Corticosteroid Injections Before and After Initial Treatment of Knee Osteoarthritis with Hylan G-F 20
por: Khangulov, Victor, et al.
Publicado: (2020)

Efficacy and Safety of Hylan G-F 20 Versus Intra-Articular Corticosteroids in People with Knee Osteoarthritis: A Systematic Review and Network Meta-Analysis
por: Chevalier, Xavier, et al.
Publicado: (2020)

Impact of obesity, structural severity and their combination on the efficacy of viscosupplementation in patients with knee osteoarthritis
por: Conrozier, Thierry, et al.
Publicado: (2019)

Viscosupplementation for Management of Knee Osteoarthritis from an Indian Perspective: An Expert Consensus Report
por: Tapasvi, Sachin, et al.
Publicado: (2019)

Intraarticular triamcinolone hexacetonide, stanozolol, Hylan G-F 20 and platelet concentrate in a naturally occurring canine osteoarthritis model
por: Alves, J. C., et al.
Publicado: (2021)

Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial
por: Wang, Yuanyuan, et al.
Publicado: (2011)

Long-Term (1-Year) Safety and Efficacy of a Single 6-mL Injection of Hylan G-F 20 in Indian Patients with Symptomatic Knee Osteoarthritis
por: Pal, Sarvajeet, et al.
Publicado: (2014)

One-year efficacy and safety of single or one to three weekly injections of hylan G-F 20 for knee osteoarthritis: a systematic literature review and meta-analysis
por: De Lucia, Orazio, et al.
Publicado: (2020)

VISCOSUPPLEMENTATION IN ANKLE OSTEOARTHRITIS: A SYSTEMATIC REVIEW
por: Faleiro, Thiago Batista, et al.
Publicado: (2016)

Intra-Articular Viscosupplementation for Patients with Hip Osteoarthritis: A Meta-Analysis and Systematic Review
por: Liao, Ying-Yang, et al.
Publicado: (2019)

Use of viscosupplementation for the recovery of active football players complaining of knee pain
por: Migliore, Alberto, et al.
Publicado: (2018)

Viscosupplementation in the hip: evaluation of hyaluronic acid formulations
por: van den Bekerom, M. P. J., et al.
Publicado: (2007)

VISCOSUPPLEMENTATION
por: de Rezende, Márcia Uchôa, et al.
Publicado: (2015)

Comparative Efficacy and Safety of Sulodexide and Other Extended Anticoagulation Treatments for Prevention of Recurrent Venous Thromboembolism: A Bayesian Network Meta-analysis
por: Pompilio, Giuseppe, et al.
Publicado: (2020)

Viscosupplementation for treating knee osteoarthrosis: review of the literature()
por: Ammar, Tiago Youssef, et al.
Publicado: (2015)

BRAZILIAN CONSENSUS STATEMENT ON VISCOSUPPLEMENTATION OF THE KNEE (COBRAVI)
por: de Campos, Gustavo Constantino, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g19bfnsb0oiqopubh99bf781hl